About Index Trending news
Analyze
Top 50 Pricing
Critical Outcome Technologies

Critical Outcome Technologies

Work at Critical Outcome Technologies? Add yourself to this profile

Critical Outcome Technologies

Multiple clinical trials planned for COTI-2, our p53-dependent, potential breakthrough treatment for many cancers. | Listed on the TSX Venture Exchange as COT.

Elsewhere

Alexa global traffic share

Twitter followers

25 Sep 2014
$45,758
Venture capital
01 Aug 2014
$1,300,000
Post-IPO equity
06 May 2014
$285,000
Undisclosed funding